×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by MACKAY MARTIN

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RLYBRallybio CorpMACKAY MARTINChief Executive OfficerJan 10, 2022Buy$10.105,50455,590278,113Jan 12, 2022, 06:56 PM
RLYBRallybio CorpMACKAY MARTINChief Executive OfficerJan 11, 2022Buy$10.654,49647,882282,609Jan 12, 2022, 06:56 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 27, 2017Sale$131.20860112,83238,883Mar 01, 2017, 07:45 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 28, 2017Sale$131.7062582,31238,258Mar 01, 2017, 07:45 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DMar 01, 2017Sale$132.5037049,02550,688Mar 01, 2017, 07:45 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 09, 2017Sale$126.8421727,52439,743Feb 10, 2017, 06:05 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 06, 2017Sale$125.702,728342,90439,978Feb 08, 2017, 04:39 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DMay 16, 2016Sale$139.204,097570,28442,706May 18, 2016, 04:36 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 29, 2016Sale$138.911,000138,91046,785Mar 01, 2016, 06:34 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 08, 2016Sale$138.091,966271,48142,693Feb 08, 2016, 07:56 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 05, 2016Sale$141.752,105298,37744,756Feb 08, 2016, 07:56 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DAug 03, 2015Sale$163.4087,00014,215,90676,393Aug 05, 2015, 06:09 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DMay 14, 2015Sale$160.334,056650,29832,893May 22, 2015, 05:30 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DMar 02, 2015Sale$180.3437066,72636,949Mar 03, 2015, 09:13 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DFeb 10, 2015Sale$173.973,897677,95634,126Feb 12, 2015, 09:07 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DNov 03, 2014Option Exercise$148.1918,7502,778,56333,801Nov 04, 2014, 06:36 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DJun 12, 2014Sale$135.6450,0006,782,06649,426Jun 13, 2014, 05:31 PM
ALXNALEXION PHARMACEUTICALS INCMACKAY MARTINEVP & Global Head of R&DMay 14, 2014Sale$160.853,574574,87824,426May 15, 2014, 05:11 PM